For the treatment of liver cancer, AP may suppress tumor growth of HCC through the long non-coding RNA H19-mediated Wnt/β-catenin signaling regulatory axis, which indicated that the H19 was a potential therapeutic target for HCC (Pan et al., 2021). The gene discussed is H19; the disease is liver cancer.